...
首页> 外文期刊>Infection, Disease & Health >Biopatch? or Kendall? AMD foam disc to reduce the incidence of central-line-associated blood stream infection: A feasibility study
【24h】

Biopatch? or Kendall? AMD foam disc to reduce the incidence of central-line-associated blood stream infection: A feasibility study

机译:生物补丁?还是肯德尔? AMD泡沫盘减少中心线相关血流感染的发生率:一项可行性研究

获取原文

摘要

Introduction: During 2014, Tasmanian Infection Prevention and Control(TIPCU) in conjunction with the Tasmanian Antimicrobial StewardshipNetwork (TASNET) developed and piloted an antimicrobial surveillancemodule for rural hospitals. This was used in 2015 in all 13 Tasmanian ruralhospitals to assess antimicrobial use.Methods: During August 2015, data were collected by nursing staff for allacute care inpatients within rural hospitals who were prescribed antimicrobial treatment. Information collected included rationale for treatment, drugname, dosage, duration of therapy and microbiological testing. Appropriateness of therapy was assessed against the Therapeutic Guidelines:Antibiotic v15 2014. Where possible, results were compared with the 2014National Antimicrobial Prescribing Survey (NAPS).
机译:简介:2014年,塔斯马尼亚州感染预防与控制(TIPCU)与塔斯马尼亚州抗菌素管理网络(TASNET)联合开发并试行了针对农村医院的抗菌素监测模块。 2015年,塔斯马尼亚州的所有13家农村医院均使用了该方法来评估抗菌药物的使用。方法:2015年8月,护理人员收集了农村医院内接受抗菌药物治疗的所有急诊患者的数据。收集的信息包括治疗理由,药物名称,剂量,治疗持续时间和微生物检测。根据《治疗指南:抗生素v15 2014》评估了治疗的适当性。在可能的情况下,将结果与2014年美国国家抗菌药物处方调查(NAPS)进行了比较。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号